John W. Beck, Chief Financial Officer at METABASIS THERAPEUTICS INC (MBRX), sold 3,000 shares at $8.00 ($24K) on 2006-12-05, disclosed to the SEC on 2006-12-05.
Scheduled sale ($24k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RDEA | SELL | 2009-08-17 | $50K | — | Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-21 | $27K | — | Filing → |